FP6Докторантска мрежа2006–2010

ENDOCYTE · The intracellular routes of growth factor signalling from the plasma membrane to the nucleus

6РП — Действия „Мария Кюри“

Период
2006-09-01 → 2010-08-31
Финансиране от ЕС
2 630 000 €
Участници
11
Схема
RTN

Линиите свързват координатора с партньорите.

Накратко на български

Механизмите на клетъчната комуникация се анализират чрез ролята на протеина CCM2 при смъртта на туморни клетки и работата на PtdIns(3)P при деленето на клетките. Тези процеси помагат за разбирането на развитието на детските невробластоми и начина, по който се контролира клетъчният цикъл.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Final Activity Report Summary - ENDOCYTE (The intracellular routes of growth factor signalling from the plasma membrane to the nucleus)

1) CCM2 mediates death signalling by the TrkA receptor tyrosine kinase: The TrkA receptor tyrosine kinase is crucial for differentiation and survival of nerve-growth-factor-dependent neurons. Paradoxically, TrkA also induces cell death in pediatric tumour cells of neural origin, via an unknown mechanism. Here, we show that CCM2, a gene product associated with cerebral cavernous malformations, interacts with the juxtamembrane region of TrkA via its phosphotyrosine binding (PTB) domain and mediates TrkA-induced death in diverse cell types. Both the PTB and Karet domains of CCM2 are required for TrkA-dependent cell death, such that the PTB domain determines the specificity of the interaction, and the Karet domain links to death pathways. Downregulation of CCM2 in medulloblastoma or neuroblastoma cells attenuates TrkA-dependent death. Combined high expression levels of CCM2 and TrkA are correlated with long-term survival in a large cohort of human neuroblastoma patients. Thus, CCM2 is a key mediator of TrkA-dependent cell death in pediatric neuroblastic tumors. 2) PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody: Several subunits of the class III phosphatidylinositol-3-OH kinase (PI(3)K-III) complex are known as tumour suppressors. Here we uncover a function for this complex and its catalytic product phosphatidylinositol-3-phosphate (PtdIns(3)P) in cytokinesis. We show that PtdIns(3)P localises to the midbody during cytokinesis and recruits a centrosomal protein, FYVE-CENT (ZFYVE26), and its binding partner TTC19, which in turn interacts with CHMP4B, an endosomal sorting complex required for transport (ESCRT)-III subunit implicated in the abscission step of cytokinesis. Translocation of FYVE-CENT and TTC19 from the centrosome to the midbody requires another FYVE-CENT-interacting protein, the microtubule motor KIF13A. Depletion of the VPS34 or Beclin 1 subunits of PI(3)K-III causes cytokinesis arrest and an increased number of binucleate and multinucleate cells, in a similar manner to the depletion of FYVE-CENT, KIF13A or TTC19. These results provide a mechanism for the translocation and docking of a cytokinesis regulatory machinery at the midbody. 3) Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers: Ligand-mediated dimerization has emerged as a universal mechanism of growth factor receptor activation. Neurotrophins interact with dimers of the p75 neurotrophin receptor (p75(NTR)), but the mechanism of receptor activation has remained elusive. Here, we show that p75(NTR) forms disulphide-linked dimers independently of neurotrophin binding through the highly conserved Cys(257) in its transmembrane domain. Mutation of Cys(257) abolished neurotrophin-dependent receptor activity but did not affect downstream signaling by the p75(NTR)/NgR/Lingo-1 complex in response to MAG, indicating the existence of distinct, ligand-specific activation mechanisms for p75(NTR). FRET experiments revealed a close association of p75(NTR) intracellular domains that was transiently disrupted by conformational changes induced upon NGF binding. Although mutation of Cys(257) did not alter the oligomeric state of p75(NTR), the mutant receptor was no longer able to propagate conformational changes to the cytoplasmic domain upon ligand binding. We propose that neurotrophins activate p75(NTR) by a mechanism involving rearrangement of disulphide-linked receptor subunits.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Growth factor receptor signalling controls an enormous variety of biological processes, during all stages of animal development and in all tissues and organs. Its importance for the understanding and treatment of human disease can not be overstated. Internalization and intracellular transport has emerged as an important regulator of signal transduction by growth factor receptors. Two parallel strategies will be used to tackle this paradigm shift and exploit the opportunities laying behind it: 1) a join t research program involving 12 teams at the international forefront of the field with the aim to understand how receptor internalization and intracellular traffic regulate signalling and biological responses in both health and disease. We will address th e functional genomics of receptor endocytosis and intracellular transport, and elucidate the molecular mechanisms by which these processes affect growth factor signalling. We will identify new genes and potential drug targets in the endocytic and intracellular transport pathways. We will build mathematical models that recapitulate receptor endocytosis and signalling in space and time, and devise chemical and genetic strategies to modify cellular responses to growth factor signalling by manipulating intracellular trafficking of receptor complexes. 2) a multidisciplinary training scheme for a cohort of 6 PhD students and 6 postdoctoral fellows from throughout Europe. They will collaborate with at least 2 centres, and participate in 12 specialist Workshops in a addition to network meetings. They will gain hands-on experience in cutting-edge techniques from across cell biology, genetics, chemistry and mathematics, and also be trained in other approaches and professional skills. This will create a community of young scientists for whom thematic and trans-national mobility will be first nature, giving them the opportunity to become future leaders in the field, either as academics or in EU industry.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз